Annual Drug Patent Expirations for ZIMHI
Zimhi is a drug marketed by Adamis Pharms Corp and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
This drug has eight patent family members in eight countries.
The generic ingredient in ZIMHI is naloxone hydrochloride. One supplier is listed for this compound. Additional details are available on the naloxone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
